Skip to main content
Policy & Issues Forum (P&I) 2025 Main banner
Back

340B Compliance and Policy

PSaA1 - The New and Changing 340B Landscape: Legislative, Litigation, and Policy Updates

Saturday, February 8, 2025
8:00 AM – 9:15 AM ET
Location: Marquis Ballroom Salons 5-10 (M2)
Knowledge Level: Basic
CPE: 1.5
CME: 1.25
CE: 1.0
CEU: 1.25
Session Description: The federal statute, enacted as Section 340B of the Public Health Act, that requires drug manufacturers to offer a discounted ceiling price on outpatient prescription drugs offers savings essential to reliable and sustainable funding for qualifying health centers. However, the 340B program faces ever-changing and increasing challenges from manufacturers, prescription benefit managers, and others. This session will begin with the 340B Prime Vendor overviewing current market trends then panelist will provide attendees with a digestible update on the most recent legal, legislative, and federal/state challenges affecting health center participation in 340B and will provide attendees with actionable steps their health centers can take to optimize their 340B savings in a rapidly changing landscape.

340B Day attendance is closed to media and requires P&I registration.

Learning Objectives:

  • Upon completion, participants will be able to apply recent changes in the 340B program landscape to revisit and potentially modify their health center's 340B practices, policies, and procedures.
  • Upon completion, participants will be able to present actionable steps for their health center to respond to potential rebate models proposed by manufacturers in the 340B program.
  • Upon completion, participants will be able to present actionable steps to become more involved in activism and advocacy related to health center participation in the 340B program.